Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Sexually Transmitted Diseases Therapeutics Market Research Reports

Titlepublishedprice

Bacterial Vaginosis - Pipeline Review, H1 2017

By Global Markets Direct
"...... inal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin. Treatment includes antibiotics.Report Highlights......"
28-Feb-2017$2000

Global Sexually Transmitted Diseases Partnering 2010-2017

By Current Partnering
"...... ion The Global Sexually Transmitted Diseases Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. ......"
01-Feb-2017$1495

Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s to understand the market and pipeline status of the drugs around the Genital Herpes to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Rep......"
01-Jan-2017$2000

Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... stand the market and pipeline status of the drugs around the Gonorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides th......"
01-Jan-2017$2000

Bacterial Vaginosis-Pipeline Insights, 2017

By Delve Insight
"...... nical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA desig......"
01-Jan-2017$1250

Syphilis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Syphilis - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... s market revenue; average cost of therapy, treatment practice and Syphilis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Syphilis till 2023......."
01-Jan-2017$4950

Chlamydia Infections-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Condyloma-Pipeline Insights, 2017

By Delve Insight
"...... Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Del......"
01-Jan-2017$1250

Syphilis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... and the market and pipeline status of the drugs around the Syphilis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the h......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.